Mubasher: Arcapita Group Holdings and Bahrain Mumtalakat Holding Company, the sovereign wealth fund of Bahrain, have sold their stake in NAS Neuron Health Services to a US-based Fortune 500 company.

The successful investment has exceeded target returns over a three-year holding period, according to a press release on Monday.

In 2017, Arcapita and Mumtalakat acquired an equity stake in NAS United Healthcare Services and over the past three years, the consortium supported the company’s execution of a series of organic and inorganic growth initiatives.

Today NAS Neuron is one of the largest private TPAs of medical claims in the GCC, serving over 1.3 million lives across the GCC region.

“Healthcare and wellness are among Arcapita’s focus areas for both our private equity and real estate platforms, given the demographic tailwinds supporting this sector. We plan to continue focusing on defensive sectors that are supported by long-term market fundamentals,” said Arcapita’s CEO, Atif A. Abdulmalik.  

For his part, CEO of Mumtalakat, Khalid Al Rumaihi, noted, “Our strategic partnership with Arcapita enabled us to support and witness NAS Neuron’s progress into one of the leading players in the GCC health sector with a solid management structure and a clear vision to continue on its growth trajectory.”

"Backed by strong strategic shareholders, including Arcapita and Mumtalakat, we successfully brought together the strengths of NAS and Neuron to benefit the wider healthcare industry. I am personally grateful for the trust placed in me by the shareholders, and I look forward to continuing to enhance our value proposition,” Group CEO of NAS Neuron, Umair Nizami, concluded.